Mark Reilly, former chief of GSK in China, will be deported from the country, avoiding jail time there in a corruption scandal, sources say.» Read More
Several court challenges to a key part of Obamacare could lead to average premium increases of 76 percent for subsidized HealthCare.gov enrollees.
U.S. drugmaker announces plans to take over Dublin-based Shire in a deal that will help AbbVie lower its tax rate by buying a foreign rival.
FedEx was indicted for shipping packages from illegal online pharmacies despite repeated warnings from U.S. drug enforcement officials.
Over 100 AIDS activists on route to a conference in Melbourne were on board MH17 which crashed in Ukraine, several Australian media sources reported.
States may be on the hook for $55 billion to pay for hepatitis C treatments like Sovaldi, a new study says.
Sanofi talked with Abbott Laboratories, Mylan and private equity firms over selling a portfolio of mature drugs, according to a document.
Novartis and Google have agreed to develop "smart" contact lenses to help diabetics track blood glucose levels or restore the eye's ability to focus.
Many choose to hire a caregiver through a geriatric care manager, or GCM, or by finding someone on their own.
Most millennials use alternative medicine to maintain wellbeing rather than cure existing sicknesses. The Fiscal Times reports.
A huge merger between tobacco giants Reynolds American and Lorillard will see electronic cigarette leader blu go to another company.
Hundreds have died in West Africa from the Ebola virus. With no known cure and a high mortality rate, alarm is real.
The liver disease NASH is becoming more widespread, and the market for treatments may rival those for hepatitis C.
Venture capital investment in health-care IT companies has topped $2.3 billion in 2014, blowing past the $1.9 billion in funding for all of 2013.
Some users find that their bands actually make them pack on the pounds as opposed to shedding weight. The TODAY Show reports.
Sales of newer prescription drugs helped boost Johnson & Johnson's earnings to a level much higher than expected.
Increasingly, drug makers and medical device companies have found a way to self-medicate when it comes to taxes and regulation.
A new study has found co-sleeping to be associated with a higher risk of death, especially among infants under 4 months of age, Today reports.
It could take a "couple of years" to figure out the full costs of Obamacare to health-care providers, Kaiser Permanente chief Bernard Tyson tells CNBC.
Mylan said it would buy Abbott Labs' generics business outside the United States in an all-stock transaction valued at about $5.3 billion.
London-listed pharma says it's ready to recommend a newly revised higher offer from AbbVie, valuing the drugmaker at $90.53 per share.
Get the best of CNBC in your inbox